Apoptotic resistance in chronic lymphocytic leukemia and therapeutic perspectives.


Journal

Critical reviews in clinical laboratory sciences
ISSN: 1549-781X
Titre abrégé: Crit Rev Clin Lab Sci
Pays: England
ID NLM: 8914816

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 3 4 2019
medline: 29 7 2020
entrez: 3 4 2019
Statut: ppublish

Résumé

Increased resistance to apoptosis represents a key oncogenic mechanism in chronic lymphocytic leukemia (CLL) that has been attributed to the upregulation of the anti-apoptotic B cell lymphoma 2 (Bcl-2) family members. Such an observation was associated with the development of molecules inhibiting Bcl-2 activity, and among them, BH3-mimetics represent a novel class of therapeutic compounds. In 2016, venetoclax became the first approved oral inhibitor of Bcl-2, and it has been used with success in patients with CLL who present with a 17p deletion or

Identifiants

pubmed: 30935269
doi: 10.1080/10408363.2019.1600468
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

321-332

Auteurs

Cristina Bagacean (C)

a Department of Hematology , Brest University Medical School Hospital , Brest , France.
b U1227 B Lymphocytes and Autoimmunity , University of Brest, INSERM, IBSAM , Brest , France.
c Laboratory of Immunology and Immunotherapy , Brest University Medical School Hospital , Brest , France.

Ciprian Tomuleasa (C)

d Research Center for Functional Genomics and Translational Medicine , "Iuliu Hatieganu" University of Medicine and Pharmacy , Cluj-Napoca , Romania.

Adrian Tempescul (A)

a Department of Hematology , Brest University Medical School Hospital , Brest , France.
b U1227 B Lymphocytes and Autoimmunity , University of Brest, INSERM, IBSAM , Brest , France.

Ravnit Grewal (R)

e South African National Bioinformatics Institute (SANBI) , University of the Western Cape , Cape Town , South Africa.

Wesley H Brooks (WH)

f Department of Chemistry , University of South Florida , Tampa , FL , USA.

Christian Berthou (C)

a Department of Hematology , Brest University Medical School Hospital , Brest , France.
b U1227 B Lymphocytes and Autoimmunity , University of Brest, INSERM, IBSAM , Brest , France.

Yves Renaudineau (Y)

c Laboratory of Immunology and Immunotherapy , Brest University Medical School Hospital , Brest , France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH